FTC sues key pharmacy reward managers over insulin selling prices The company brought motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of daily life-conserving insulin drugs. Before this summer season, the business held lengthy negotiations with Steward about https://judahcgcwr.bluxeblog.com/62733577/the-smart-trick-of-healthcare-news-that-no-one-is-discussing